Kuzan, A.; Kozak-Sykała, A.; Fiedorowicz, A.; Kałas, W.; Strządała, L.; Gamian, A.
Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients. J. Clin. Med. 2024, 13, 443.
https://doi.org/10.3390/jcm13020443
AMA Style
Kuzan A, Kozak-Sykała A, Fiedorowicz A, Kałas W, Strządała L, Gamian A.
Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients. Journal of Clinical Medicine. 2024; 13(2):443.
https://doi.org/10.3390/jcm13020443
Chicago/Turabian Style
Kuzan, Aleksandra, Anna Kozak-Sykała, Anna Fiedorowicz, Wojciech Kałas, Leon Strządała, and Andrzej Gamian.
2024. "Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients" Journal of Clinical Medicine 13, no. 2: 443.
https://doi.org/10.3390/jcm13020443
APA Style
Kuzan, A., Kozak-Sykała, A., Fiedorowicz, A., Kałas, W., Strządała, L., & Gamian, A.
(2024). Advanced Glycation End-Products in Blood Serum—Novel Ischemic Stroke Risk Factors? Implication for Diabetic Patients. Journal of Clinical Medicine, 13(2), 443.
https://doi.org/10.3390/jcm13020443